These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 32406632)

  • 1. Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia?
    Burbery R
    J Law Med; 2020 Apr; 27(3):718-740. PubMed ID: 32406632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
    Bellver Capella V
    Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legality of Embryonic Gene Editing in Australia.
    Taylor-Sands M; Gyngell C
    J Law Med; 2018 Dec; 26(2):356-373. PubMed ID: 30574724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upstream Ethical Mapping of Germline Genome Editing.
    Halpern J; Paolo D
    Am J Bioeth; 2020 Aug; 20(8):1-4. PubMed ID: 32804067
    [No Abstract]   [Full Text] [Related]  

  • 6. Trust in Science: CRISPR-Cas9 and the Ban on Human Germline Editing.
    Guttinger S
    Sci Eng Ethics; 2018 Aug; 24(4):1077-1096. PubMed ID: 28653169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.
    Schleidgen S; Dederer HG; Sgodda S; Cravcisin S; Lüneburg L; Cantz T; Heinemann T
    BMC Med Ethics; 2020 Sep; 21(1):87. PubMed ID: 32912206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Human Right to Science and the Regulation of Human Germline Engineering.
    Boggio A; Knoppers BM; Almqvist J; Romano CPR
    CRISPR J; 2019 Jun; 2():134-142. PubMed ID: 31225756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The trust game: CRISPR for human germline editing unsettles scientists and society.
    Braun M; Meacham D
    EMBO Rep; 2019 Feb; 20(2):. PubMed ID: 30602586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Genome Editing and Ethical Considerations.
    Krishan K; Kanchan T; Singh B
    Sci Eng Ethics; 2016 Apr; 22(2):597-9. PubMed ID: 26154417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas System: Recent Advances and Future Prospects for Genome Editing.
    Manghwar H; Lindsey K; Zhang X; Jin S
    Trends Plant Sci; 2019 Dec; 24(12):1102-1125. PubMed ID: 31727474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islamic Perspectives on CRISPR/Cas9-Mediated Human Germline Gene Editing: A Preliminary Discussion.
    Isa NM; Zulkifli NA; Man S
    Sci Eng Ethics; 2020 Feb; 26(1):309-323. PubMed ID: 30830592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Council of Europe should not reaffirm the ban on germline genome editing in humans.
    Sykora P; Caplan A
    EMBO Rep; 2017 Nov; 18(11):1871-1872. PubMed ID: 28986351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
    Meng X; Zhou H; Xu S
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human germline editing: a historical perspective.
    Morange M
    Hist Philos Life Sci; 2017 Oct; 39(4):34. PubMed ID: 29038945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress of CRISPR-Cas9 system for gene therapy].
    Zhan C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.